|
|
| Morningstar Overall Rating: |
 |
| Total Assets: |
274.50M |
| Category: |
Health |
| Total Expense Ratio: |
1.12% |
|
| PERFORMANCE & RISK | 31-Jan-10
| YTD Return: |
-0.09% |
| 5y Avg Return: |
6.63% |
| Rank in Category (ytd): |
74 |
| % Rank in Category (ytd): |
44.58% |
| Beta (3y): |
1.05 |
| Morningstar Risk Rating: |
Above average |
|
| The investment seeks long-term growth. The fund invests at least 80% of assets in securities of companies involved in the life sciences industry. It may invest in U.S. and foreign stocks, including American Depository Receipts (ADRs) and other U.S. dollar denominated securities of foreign issuers. The fund is nondiversified. |
|
| Fund Profile |
|
Help
0.13 (1.24%) 
Summary
Add EXLSX to Portfolio 
Download Data
